Doxazosin mesylate
Doxazosin Mesylate is a prescription medication available as oral tablets in strengths of 1mg, 2mg, 4mg, and 8mg. It belongs to the class of alpha-adrenergic blockers and is used to treat high blood pressure and symptoms of an enlarged prostate. Manufactured by Upsher-Smith Laboratories, LLC, under application ANDA209013. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Doxazosin Mesylate is a prescription medication available as oral tablets in strengths of 1mg, 2mg, 4mg, and 8mg. It belongs to the class of alpha-adrenergic blockers and is used to treat high blood pressure and symptoms of an enlarged prostate. Manufactured by Upsher-Smith Laboratories, LLC, under application ANDA209013. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Doxazosin mesylate", "mediaType": "text/html", "description": " Access the FDA dataset for Doxazosin mesylate — ANDA 209013 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209013" } ] |
| identifier | ANDA209013 |
| issued | 2016-09-16 |
| keyword |
[ "drug-safety", "fda", "health-care", "medications", "public-health" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Doxazosin mesylate |
